673 filings
Page 25 of 34
8-K
gfnjrlj8287o
30 Mar 10
BioSante Pharmaceuticals Reports Receipt of $2.16 Million in Elestrin™Royalty Buydown, and Financial Results for 2009
12:00am
CORRESP
p01umb
10 Mar 10
Correspondence with SEC
12:00am
424B5
uvhaqkgv92jqlp9399n6
5 Mar 10
Prospectus supplement for primary offering
12:00am
8-K
izz 5koldv4983
5 Mar 10
BioSante Pharmaceuticals to Raise $18 Million in Registered Direct Offering
12:00am
UPLOAD
ce98jcm
4 Mar 10
Letter from SEC
12:00am
CORRESP
31s4zjym
7 Jan 10
Correspondence with SEC
12:00am
CORRESP
ioo l1g1s
17 Dec 09
Correspondence with SEC
12:00am
UPLOAD
pljj 33s0
15 Dec 09
Letter from SEC
12:00am
8-K
q4ur4 gg3fj
9 Nov 09
BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results
12:00am
8-K
v3scji5ln914a
14 Oct 09
Entry into a Material Definitive Agreement
12:00am
425
ifvo4ry 0zntr
30 Sep 09
Business combination disclosure
12:00am
425
nmumx2d 4o2b
23 Sep 09
Business combination disclosure
12:00am
8-K
jqq9xbjg lpgpbx
21 Sep 09
Other Events
12:00am
425
uwfifhi3jo0fqbh
21 Sep 09
Business combination disclosure
12:00am
425
p9c1uqulw02x6
17 Sep 09
Business combination disclosure
12:00am
425
i68ho
3 Sep 09
Business combination disclosure
12:00am
424B3
as5b5rfy5im u0zu4ft
24 Aug 09
Prospectus supplement
12:00am
EFFECT
8c18a vdtdjozehc
21 Aug 09
Notice of effectiveness
12:00am